← All stocks

Bluejay Diagnostics, Inc.

BJDX Net buying
CIK 0001704287 #5618 in the set updated 18 Sep 2026
Bought (12 mo)
$221.71K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$48.91K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$48.91K
1 of 1 sales
Net
+$172.80K
+$172.80K against sales at will

By person

6 insiders · 7 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
HRT FINANCIAL LP entity
10% owner
$96.71K (1)
$48.91K (1)
+$47.80K
92,055
$128.88K
+46.2%
CHASE DONALD R
Director
$25.00K (1)
+$25.00K
12,525
$17.54K
+50,000%
Dey Indranil
President and CEO
$25.00K (1)
+$25.00K
40,522
$56.73K
+184,091%
Dey Svetlana
Director
$25.00K (1)
+$25.00K
12,501
$17.50K
+1,250,000%
Wurth Douglas Clark
Director
$25.00K (1)
+$25.00K
12,608
$17.65K
+11,574%
ZEIDMAN FRED S
Director
$25.00K (1)
+$25.00K
12,500
$17.50K

No percentages here. This company's share count has moved by a factor of 48.5 over the window, from 554,012 to 26,883,971 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
HRT FINANCIAL LP
9 Jul 2026
10% owner
Buy
64,047
$1.51
$96.71K
Dey Svetlana
14 Mar 2026
Director
Buy
12,500
$2.00
$25.00K
ZEIDMAN FRED S
14 Mar 2026
Director
Buy
12,500
$2.00
$25.00K
CHASE DONALD R
14 Mar 2026
Director
Buy
12,500
$2.00
$25.00K
Dey Indranil
14 Mar 2026
President and CEO
Buy
12,500
$2.00
$25.00K
Wurth Douglas Clark
14 Mar 2026
Director
Buy
12,500
$2.00
$25.00K

What was left out

Form 4 filings counted 13
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 28,000
History held since 17 Dec 2021